QPS Holdings Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • QPS Holdings's estimated annual revenue is currently $154.2M per year.(i)
  • QPS Holdings's estimated revenue per employee is $201,000

Employee Data

  • QPS Holdings has 767 Employees.(i)
  • QPS Holdings grew their employee count by 6% last year.

QPS Holdings's People

NameTitleEmail/Phone
1
Chairman, President and CEOReveal Email/Phone
2
Executive Director Early Phase Clinical Business DevelopmentReveal Email/Phone
3
Chief Operating Officer / Chief Administrative OfficerReveal Email/Phone
4
VP and Global Head DMPKReveal Email/Phone
5
VP FinanceReveal Email/Phone
6
Head Project Management - Translational MedicineReveal Email/Phone
7
VP, Head Global MarketingReveal Email/Phone
8
VP & General ManagerReveal Email/Phone
9
VP, Global Head Medical AffairsReveal Email/Phone
10
SVP, Global Head Late Phase ClinicalReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$44.4M22131%N/AN/A
#2
$10.3M51-27%N/AN/A
#3
$83.2M4146%N/AN/A
#4
$59.9M298-9%N/AN/A
#5
$9.4M4742%N/AN/A
#6
$136.3M678-8%N/AN/A
#7
$29.9M14913%N/AN/A
#8
$0.7M70%N/AN/A
#9
$3M1550%N/AN/A
#10
$9.6M487%N/AN/A
Add Company

What Is QPS Holdings?

Bio-Kinetic Clinical Applications, the choice for your next Phase I study, is located in Springfield, MO. Founded in 1994 by Dale Bourg and Dave Koenigsfeld, BKCA has grown from a 12 bed facility to its current capacity of 240 beds with our new expansion. We also have an established relationship with Bio-Kinetic Europe, located in Belfast, North Ireland, to offer you global Phase I capabilities to meet your needs.

keywords:N/A

N/A

Total Funding

767

Number of Employees

$154.2M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

QPS Holdings News

2022-04-13 - Diamond Fields Files Amended and Re-stated NI 43-101 ...

Geol (collectively the “QPs”). ... Labola Project and confirming that the QPs are independent from the Company, Moydow Holdings Limited and...

2022-04-06 - Global Appetite (Eating) Disorders Clinical Trials Review 2022 ...

Takeda Pharmaceutical Co Ltd; Tsumura & Co; Insys Therapeutics Inc (Inactive); QPS Holdings LLC; Opiant Pharmaceuticals Inc...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$282.5M8893%N/A
#2
$232.6M92311%N/A
#3
$375.4M9936%N/A
#4
$285.6M99510%N/A
#5
$423M11195%N/A